Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT

Clinical trial NCT04952350 · UNKNOWN

Trial details

NCT number: NCT04952350
Sponsor: Mansoura University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 SARS-CoV2 Infection COVID-19 Pneumonia

Start date: 2021-08-14
Primary completion: 2021-11-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.